Arie Mayer - Apr 3, 2023 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Arie Mayer
Stock symbol
ORMP
Transactions as of
Apr 3, 2023
Transactions value $
$19,518
Form type
4
Date filed
4/4/2023, 05:10 PM
Previous filing
Aug 1, 2022
Next filing
Apr 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Purchase $11.1K +5.01K +27.83% $2.22 23K Apr 3, 2023 Direct F1
transaction ORMP Common Stock Purchase $8.4K +3.8K +16.52% $2.21 26.8K Apr 4, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.17 to $2.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.